Evaluation of an interferon-gamma release assay, T-SPOT®.TB, in a population with a low prevalence of tuberculosis
OBJECTIVE: To compare the performance of an interferon-gamma release assay (T-SPOT®.TB) and tuberculin skin test (TST) in a population with a low prevalence of tuberculosis (TB) that was predominantly US-born and not bacille Calmette-Guérin-vaccinated.
DESIGN: A total of 414 subjects with absence of a previous positive TST were enrolled, of whom 326 yielded analyzable results for both TST and T-SPOT.TB.
RESULTS: Overall agreement between T-SPOT.TB and TST was 98.2% (95%CI 96.0–99.3). The specificity of T-SPOT.TB in individuals judged to be at low risk for TB infection was 98.9% (95%CI 96.9–99.8). Of 326 subjects, 8 (2.5%) had a positive T-SPOT.TB result, six of which occurred in the absence of a positive TST. Of these, at least three appeared to have risk factors, suggesting the possibility of a false-negative TST result.
CONCLUSION: Because of the excellent agreement between the TSPOT.TB and the TST, either test can serve as an effective diagnostic tool in populations at low risk for TB. As the tests have specific advantages and disadvantages, health care providers have leeway in choosing the most appropriate test for the population they are treating.
Keywords: T-SPOT.TB; TST; interferon-gamma; latent TB; tuberculosis
Document Type: Regular Paper
Affiliations: Naval Institute for Dental and Biomedical Research, Great Lakes, Illinois, USA; and General Dynamics Information Technology, Frederick, Maryland, USA
Publication date: 01 November 2009
The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.
The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites
Receive new issue alert- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content